5th Annual Cleveland Breast Cancer Summit: Collaborating For A Cure
H

Enhancing the Impact of IO in Metastatic / Locally Advanced TNBC: Atezolizumab + Nab-Paclitaxel Improved PFS and OS - Results of IMpassion130 Trial

By 5th Annual Cleveland Breast Cancer Summit: Collaborating For A Cure FEATURING Hope Rugo
November 28, 2019
0 Comments
Login to view comments. Click here to Login

Featured Video

18:15
Novartis Oncology

CDK4/6 Inhibitor in Postmenopausal Patients With HR+/HER2- mBC: Anal…

Feat. G. Hortobagyi

Featured Video

20:49
Novartis Oncology

An Expert Discussion on the Overall Survival, Time to Chemotherapy, …

Feat. A. Bardia

Related Content

AUTOPLAY
11:31
Insights from 2023 ASCO® Annual Meeting

ASCO® 2023 Top 5 Abstracts Summary: "SONIA, NATALEE, PHERGain, …

Feat. P. Tarantino
49:07
SABCS 2022 Conference Coverage

SABCS 2022 Expert Panel Discussion: Practice-Changing Updates

Feat. J. O'Shaughnessy, S. Tolaney, S. Hurvitz, H. Rugo
04:28
Insights from 2023 ASCO® Annual Meeting

ASCO® 2023 Insights: "ASCENT-05/OptimICE-RD (AFT-65): Adjuvant …

Feat. S. Tolaney
24:36
ESMO 2022 Conference Coverage

ESMO 2022 Breast Cancer Panel Discussion: Practice-Changing Updates

Feat. H. Rugo, J. O'Shaughnessy
23:58
Insights from 2023 ASCO® Annual Meeting

ASCO® 2023 Summary: "mBC Expert Panel Discussion on Key Trials …

Feat. H. Rugo, K. Jhaveri
17:20
Insights from 2023 ESMO Annual Meeting

ESMO 2023 Summary: "Top 5 Breast Cancer Studies Including KEYNO…

Feat. P. Tarantino
57:44
Vogl, NY

Vogl,NY on How to Ask Good Questions at Medical Meetings

Feat. S. Vogl
07:50
Oncology Data Advisor

ESMO 2023 Insights: "Real-World Use Patterns, Effectiveness, &a…

Feat. K. Kalinsky
30:46
Insights from 2023 ESMO Annual Meeting

ESMO 2023 Panel Discussion: "Metastatic Breast Cancer"

Feat. S. Tolaney, H. Rugo
17:04
Novartis Oncology

Discussion on Overall Survival Data Across 3 Phase III Trials in HR+…

Feat. G. Hortobagyi
20:42
Total Health

2022 Updates in TNBC

Feat. I. Schlam
06:47
UCSF School of Medicine

Tumor-Agnostic Efficacy & Safety of Selpercatinib in RET Fusion+…

Feat. H. Kang
06:57
Insights from 2023 ASCO® Annual Meeting

ASCO® 2023 Insights: "ESR1 Mutational Landscape and Impact of C…

Feat. A. Medford
22:29
ESMO 2022 Conference Coverage

ESMO 2022 on Adjuvant Endocrine Therapy for BC: Who Needs More Than …

Feat. E. de Azambuja
03:36
ecancer

ESMO 2023 Insights: "Phase 3 TROPION-Breast01 Trial - Datopotam…

Feat. A. Bardia
02:05
ecancer

ESMO 2023 Insights: "CheckMate 7FL Phase 3 Study - Nivo or Plac…

Feat. S. Loi
26:28
2023 West Oncology Conference

Antibody Drug Conjugates for Breast Cancer: The End of Chemotherapy?

Feat. L. Schwartzberg
07:27
Jason Levy

Opus One: Final Results - RFA in Axial Skeleton

16:08
Insights from 2023 ASCO® Annual Meeting

ASCO® 2023 Insights: "Tailoring Post-Neoadjuvant Therapy in TNB…

Feat. H. Han
07:49
ESMO Breast Cancer 2023 Congress Coverage

ESMO Breast Cancer 2023 KEYNOTE-355 Trial: Outcomes in TNBC Patients…

Feat. H. Rugo